Busetto, G. M., Finati, M., Chirico, M., Cinelli, F., D'Altilia, N., Falagario, U. G., . . . Cormio, L. (2023). Conservative treatment for high-risk NMIBC failing BCG treatment: Who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? World Journal of Urology, 41(5), 1329-1335. https://doi.org/10.1007/s00345-023-04372-5

Busetto, Gian Maria, et al. "Conservative Treatment for High-risk NMIBC Failing BCG Treatment: Who Benefits from Adding Electromotive Drug Administration (EMDA) of Mitomycin C (MMC) to a Second BCG Induction Cycle?" World Journal of Urology 41, no. 5 (2023): 1329-1335. https://doi.org/10.1007/s00345-023-04372-5.

Busetto, Gian Maria, et al. "Conservative Treatment for High-risk NMIBC Failing BCG Treatment: Who Benefits from Adding Electromotive Drug Administration (EMDA) of Mitomycin C (MMC) to a Second BCG Induction Cycle?" World Journal of Urology, vol. 41, no. 5, 2023, pp. 1329-1335, https://doi.org/10.1007/s00345-023-04372-5.